Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Return on Assets (2022 - 2025)

Historic Return on Assets for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.1%.

  • Century Therapeutics' Return on Assets rose 2200.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.35% for FY2024, which is 300.0% down from last year.
  • Century Therapeutics' Return on Assets amounted to 0.1% in Q3 2025, which was up 2200.0% from 0.08% recorded in Q2 2025.
  • Century Therapeutics' Return on Assets' 5-year high stood at 0.07% during Q1 2025, with a 5-year trough of 0.38% in Q1 2024.
  • Over the past 4 years, Century Therapeutics' median Return on Assets value was 0.3% (recorded in 2023), while the average stood at 0.26%.
  • As far as peak fluctuations go, Century Therapeutics' Return on Assets tumbled by -1100bps in 2024, and later skyrocketed by 3100bps in 2025.
  • Over the past 4 years, Century Therapeutics' Return on Assets (Quarter) stood at 0.26% in 2022, then crashed by -37bps to 0.36% in 2023, then increased by 5bps to 0.34% in 2024, then soared by 71bps to 0.1% in 2025.
  • Its Return on Assets stands at 0.1% for Q3 2025, versus 0.08% for Q2 2025 and 0.07% for Q1 2025.